Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

101.03 -3.65 (-3.49%)
Streaming Delayed Price Updated: 12:18 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,956,047
Open 102.39
Bid (Size) 101.02 (1)
Ask (Size) 101.04 (3)
Prev. Close 104.68
Today's Range 99.75 - 104.14
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 2.02%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth
Abbott Laboratories reported Q2 sales of $10.38 billion, driven by 10.2% growth in Medical Devices, beating EPS estimates with $1.14 per share. Key highlights include FDA approval for two glucose... 
Via Benzinga
Exposures Product Safety

Performance

YTD
-8.03%
-8.03%
1 Month
-2.34%
-2.34%
3 Month
-4.60%
-4.60%
6 Month
-11.32%
-11.32%
1 Year
-5.54%
-5.54%

More News

Read More
Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised
Via Investor's Business Daily
Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
Via Benzinga
Topics Economy
Exposures Interest Rates
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
7 Analysts Have This To Say About Abbott Laboratories
Via Benzinga
Market Whales and Their Recent Bets on ABT Options
Via Benzinga
2 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions
Via Benzinga
Topics Government
Exposures Political
D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Dow Closes At New High As Q2 Earnings Season Heats Up
Via Talk Markets
Topics Stocks
Exposures US Equities
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
Via Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
Via InvestorPlace
U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist
From Financial Buzz Media
Via GlobeNewswire
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
Via InvestorPlace
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
The 3 Best Healthcare Stocks to Buy in July 2024
Via InvestorPlace
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 MedTech Stocks to Buy for Healthy Gains
Via InvestorPlace
Stocks Going Ex Dividend In July 2024
Via Talk Markets
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
Via InvestorPlace
Top Analyst Reports For Abbott, BP & Gilead
Via Talk Markets
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.